Skip to main content
FinSpry Logo
FinSpry
ACAD logo
ACAD
(NASDAQ)
ACADIA Pharmaceuticals Inc.
$29.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ACADIA Pharmaceuticals Inc. (ACAD) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for ACADIA Pharmaceuticals Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$33.00
↑ 9.24% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ACAD Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Ananda Ghosh
HC Wainwright
BuyReiterates
$33.00 → $27.00
Brian Abrahams
RBC Capital
BuyMaintains
$29.00 → $36.00
Tazeen Ahmad
BofA Securities
BuyReiterates
$29.00 → $30.00
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$32.00 → $36.00
Ananda Ghosh
HC Wainwright
BuyMaintains
$37.00
David Hoang
Deutsche Bank
BuyMaintains
$32.00 → $37.00
Ritu Baral
TD Cowen
BuyMaintains
$37.00
Yigal Nochomovitz
Citi
BuyReiterates
$35.00
Sean Laaman
Morgan Stanley
HoldMaintains
$26.00

Frequently Asked Questions

What is the analyst consensus rating for ACAD?

The analyst consensus rating for ACAD is "Buy" based on 8 analyst recommendations.

What is the average price target for ACAD?

The average 12-month price target for ACAD is $33.00, representing an upside of 9.2% from the current price of $30.21.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.